Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation

MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

View More »

Google Scholar citation report
Citations : 2051

Journal of Vaccines & Vaccination received 2051 citations as per Google Scholar report

Flyer image
Journal of Vaccines & Vaccination peer review process verified at publons
Flyer image
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Open Access Journals
View More

Michel Stoffel

Michel Stoffel

Glaxo Smith Kline Biologicals, Wavre, Belgium

Biography
Dr. Michel Stoffel is Vice President Global Regulatory Affairs, Head of Early portfolio and Head of Europe region at GSK Vaccines since 2012. He leads a global team of experts who provide strategic regulatory input into programs in early phases of development.  
Research Interest
He holds a Medical degree from the Catholic University of Louvain (UCL, Belgium). He is certified in nuclear medicine and has substantial experience in clinical research. He joined GSK in 2000 as Clinical Development Manager for hepatitis vaccines. Between 2004 to 2012, he led the Clinical Regulatory and Labelling team and was involved in the regulatory approval of more than 12 vaccines.